RankingsPricing
  1. US-listed companies
  2. IONIS PHARMACEUTICALS INC
  3. Financials
  4. Operating expenses

IONIS PHARMACEUTICALS INCIONS

Market cap
$12.9B
P/E ratio
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 20241,180+3.40%
Dec 31, 20231,141+14.42%
Dec 31, 2022998+18.67%
Dec 31, 2021841-6.73%
Dec 31, 2020901+19.11%
Dec 31, 2019757+14.47%
Dec 31, 2018661+36.83%
Dec 31, 2017483+22.95%
Dec 31, 2016393+9.31%
Dec 31, 2015359+37.26%
Dec 31, 2014262+31.64%
Dec 31, 2013199+16.36%
Dec 31, 2012171+0.46%
Dec 31, 2011170+8.52%
Dec 31, 2010157

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)